Laura Towart, Founder and CEO at Vivan Therapeutics, shared a post on LinkedIn:
“Delighted that Vivan Therapeutics has been selected by Unrest for the current Impact Investor Cohort.
Unrest has built a real platform for connecting impact investors with transformative companies, and last night’s Out of Office event was a great example — direct conversations with investors, and a room full of like-minded founders. Familiar faces and inspiring new ones alike.
At Vivan, we’re making truly personalised cancer treatment accessible — and partnerships like this move us closer to that mission.
To learn more about our personalised cancer treatment recommendations offerings please visit http://www.vivantx.com to book a complimentary consultation.”
Other articles about Vivan Therapeutics on Oncodaily.